When DZNep was combined with another HDAC inhibitor SAHA, it induced apoptosis in nonsmall cell lung cancer through the EGFR pathway in vitro and in vivo(Takashina et al., 2016).Another strategy in epigenetic therapy is targeting BET bromodomain proteins. Here, EGFR is linked to lung cancer.